In March 2025, the company introduced new plans to get a immediate-to-customer offering of its Wegovy weight loss drug. The company recognized a fresh pharmacy, referred to as NovoCare, which would demand consumers $499 every month for usage of the drug, fewer than 50 % the expense of the drug b